Free Shipping for orders over $49 within the U.S.

IN THE NEWS: Farlong Featured in Nutritional Outlook

October 18, 2021

IN THE NEWS: Farlong Featured in Nutritional Outlook

Novel ginseng extract reduced risk of cardiovascular disease risk in recent study

 

A recent randomized, placebo-controlled, triple-blind study1 found that a proprietary ginseng extract called Farlong NotoGinseng from Farlong Pharmaceutical (Walnut, CA) supported cholesterol and blood pressure. In the study 95 health participants with normal to mild hypertension and hypercholesterolemia, were either given ginseng or placebo daily for 12 weeks. Lipid profile, blood pressure, and endothelial vasodilation parameters were assessed at baseline and weeks four, eight, and 12.

 

Read the entire article on Nutritional Outlook here

Learn more about notoginseng here